MYOZ2

Myozenin 2
Identifiers
Symbols MYOZ2 ; C4orf5; CMH16; CS-1
External IDs OMIM: 605602 MGI: 1913063 HomoloGene: 9583 GeneCards: MYOZ2 Gene
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 51778 59006
Ensembl ENSG00000172399 ENSMUSG00000028116
UniProt Q9NPC6 Q9JJW5
RefSeq (mRNA) NM_016599 NM_021503
RefSeq (protein) NP_057683 NP_067478
Location (UCSC) Chr 4:
119.14 – 119.19 Mb		 Chr 3:
123.01 – 123.04 Mb
PubMed search

Myozenin-2, also referred to as Calsarcin-1, is a protein that in humans is encoded by the MYOZ2 gene.[1][2][3] The Calsarcin-1 isoform is a muscle protein expressed in cardiac muscle and slow-twitch skeletal muscle, which functions to tether calcineurin to alpha-actinin at Z-discs, and inhibit the pathological cardiac hypertrophic response. This differs from the fast-skeletal muscle isoform, calsarcin-2.

Structure

Calsarcin-1 is a 29.9 kDa protein composed of 264 amino acids.[4][5] Calsarcin-1 and calsarcin-2 are only 31% homologous (94 identical amino acids), exhibiting the highest homology at N- and C-termini. Calsarcin-1 binds to alpha-actinin,[6] gamma-filamin,[7] telethonin,[7] ZASP/Cypher[7] and calcineurin.[6] The binding region of calsarcin-1 to alpha-actinin is localized to amino acids 153-200, and that of calsarcin-1 to calcineurin is amino acids 217-240.[6]

Function

The function of calsarcin-1 in cardiac and slow-skeletal muscle has been illuminated through studies in transgenic animals. Mice lacking the MYOZ2 gene (MYOZ2-/-) are generally sensitized to calcineurin signaling in both muscle types.[8] In slow-skeletal muscle, MYOZ2-/- show increased slow-twitch muscle fibers. In cardiac, MYOZ2-/- show induction of the fetal gene program typical of pathologic hypertrophy, however there was no evidence of hypertrophied morphometry at baseline. However, upon calcineurin activation or pressure overload-induced pathologic hypertrophy, MYOZ2-/- exhibited exaggerated cardiac hypertrophy, demonstrating that calsarcin-1 negatively modulates the function of calcineurin during pathologic hypertrophic remodeling.[8] Additional studies supported these findings in demonstrating that adenoviral overexpression of calsarcin-1 attenuated Gq alpha subunit-stimuated hypertrophy and ANP induction, by Angiotensin II, phenylephrine and endothelin-1 agonists in neonatal cardiomyocytes.[9] Overexpression of calsarcin-1 in mice (CS1Tg) was protective against Angiotensin II-induced pathologic cardiac hypertrophy, evidenced by preserved fractional shortening and contractility, as well as a blunted induction of the fetal hypertrophic gene program and significantly reduced expression of calcineurin-stimulated MCIP1.4 gene expression.[9] Taken together, these studies strongly support a role for calsarcin-1 in suppressing pathologic cardiac hypertrophy.

Clinical Significance

Two missense mutations in MYOZ2, Ser48Pro and Ile246Met, have been shown to be causal for rare forms of familial hypertrophic cardiomyopathy.[10]

References

  1. ↑ Andersson B, Wentland MA, Ricafrente JY, Liu W, Gibbs RA (Apr 1996). "A "double adaptor" method for improved shotgun library construction". Analytical Biochemistry 236 (1): 107–13. doi:10.1006/abio.1996.0138. PMID 8619474.
  2. ↑ Yu W, Andersson B, Worley KC, Muzny DM, Ding Y, Liu W, Ricafrente JY, Wentland MA, Lennon G, Gibbs RA (Apr 1997). "Large-scale concatenation cDNA sequencing". Genome Research 7 (4): 353–8. doi:10.1101/gr.7.4.353. PMC 139146. PMID 9110174.
  3. ↑ "Entrez Gene: MYOZ2 myozenin 2".
  4. ↑ http://www.heartproteome.org/copa/ProteinInfo.aspx?QType=Protein%20ID&QValue=Q9NPC6}
  5. ↑ Zong, N. C.; Li, H; Li, H; Lam, M. P.; Jimenez, R. C.; Kim, C. S.; Deng, N; Kim, A. K.; Choi, J. H.; Zelaya, I; Liem, D; Meyer, D; Odeberg, J; Fang, C; Lu, H. J.; Xu, T; Weiss, J; Duan, H; Uhlen, M; Yates Jr, 3rd; Apweiler, R; Ge, J; Hermjakob, H; Ping, P (2013). "Integration of cardiac proteome biology and medicine by a specialized knowledgebase". Circulation Research 113 (9): 1043–53. doi:10.1161/CIRCRESAHA.113.301151. PMC 4076475. PMID 23965338.
  6. 1 2 3 Frey N, Richardson JA, Olson EN (Dec 2000). "Calsarcins, a novel family of sarcomeric calcineurin-binding proteins". Proceedings of the National Academy of Sciences of the United States of America 97 (26): 14632–14637. doi:10.1073/pnas.260501097. PMC 18970. PMID 11114196.
  7. 1 2 3 Frey N, Barrientos T, Shelton JM, Frank D, Rutten H, Gehring D, Kuhn C, Lutz M, Rothermel B, Bassel-Duby R, Richardson JA, Katus HA, Hill JA, Olson EN (Dec 2004). "Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress". Nature Medicine 10 (12): 1336–43. doi:10.1038/nm1132. PMID 15543153.
  8. 1 2 Frey, N; Barrientos, T; Shelton, J. M.; Frank, D; Rütten, H; Gehring, D; Kuhn, C; Lutz, M; Rothermel, B; Bassel-Duby, R; Richardson, J. A.; Katus, H. A.; Hill, J. A.; Olson, E. N. (2004). "Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress". Nature Medicine 10 (12): 1336–43. doi:10.1038/nm1132. PMID 15543153.
  9. 1 2 Frank D, Kuhn C, van Eickels M, Gehring D, Hanselmann C, Lippl S, Will R, Katus HA, Frey N (Nov 2007). "Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy". Circulation 116 (22): 2587–96. doi:10.1161/CIRCULATIONAHA.107.711317. PMID 18025526.
  10. ↑ Osio A, Tan L, Chen SN, Lombardi R, Nagueh SF, Shete S, Roberts R, Willerson JT, Marian AJ (Mar 2007). "Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy". Circulation Research 100 (6): 766–768. doi:10.1161/01.RES.0000263008.66799.aa. PMC 2775141. PMID 17347475.

Further reading

  • Faulkner G, Pallavicini A, Formentin E, Comelli A, Ievolella C, Trevisan S, Bortoletto G, Scannapieco P, Salamon M, Mouly V, Valle G, Lanfranchi G (Jul 1999). "ZASP: a new Z-band alternatively spliced PDZ-motif protein". The Journal of Cell Biology 146 (2): 465–75. doi:10.1083/jcb.146.2.465. PMC 3206570. PMID 10427098. 
  • Frey N, Richardson JA, Olson EN (Dec 2000). "Calsarcins, a novel family of sarcomeric calcineurin-binding proteins". Proceedings of the National Academy of Sciences of the United States of America 97 (26): 14632–7. doi:10.1073/pnas.260501097. PMC 18970. PMID 11114196. 
  • Ahmad F, Gonzalez O, Ramagli L, Xu J, Siciliano MJ, Bachinski LL, Roberts R (Dec 2000). "Identification and characterization of a novel gene (C4orf5) located on human chromosome 4q with specific expression in cardiac and skeletal muscle". Genomics 70 (3): 347–53. doi:10.1006/geno.2000.6399. PMID 11161785. 
  • Takada F, Vander Woude DL, Tong HQ, Thompson TG, Watkins SC, Kunkel LM, Beggs AH (Feb 2001). "Myozenin: an alpha-actinin- and gamma-filamin-binding protein of skeletal muscle Z lines". Proceedings of the National Academy of Sciences of the United States of America 98 (4): 1595–600. doi:10.1073/pnas.041609698. PMC 29302. PMID 11171996. 
  • Frey N, Olson EN (Apr 2002). "Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins". The Journal of Biological Chemistry 277 (16): 13998–4004. doi:10.1074/jbc.M200712200. PMID 11842093. 
  • Gontier Y, Taivainen A, Fontao L, Sonnenberg A, van der Flier A, Carpen O, Faulkner G, Borradori L (Aug 2005). "The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins". Journal of Cell Science 118 (Pt 16): 3739–49. doi:10.1242/jcs.02484. PMID 16076904. 
  • Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M (Oct 2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514. 
  • Posch MG, Perrot A, Dietz R, Ozcelik C, Pankuweit S, Ruppert V, Richter A, Maisch B (Jun 2007). "Mutations in MYOZ1 as well as MYOZ2 encoding the calsarcins are not associated with idiopathic and familial dilated cardiomyopathy". Molecular Genetics and Metabolism 91 (2): 207–8. doi:10.1016/j.ymgme.2007.02.014. PMID 17434779. 

External links

This article is issued from Wikipedia - version of the Wednesday, January 06, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.